The Androgen Excess and PCOS Society Criteria for the Polycystic Ovary Syndrome: The Complete Task Force Report

    October 2008 in “ Fertility and Sterility
    Ricardo Azziz, Enrico Carmina, Didier Dewailly, Evanthia Diamanti-Kandarakis, Héctor F. Escobar-Morreale, Walter Futterweit, Onno E. Janssen, Richard S. Legro, Robert J. Norman, Ann E. Taylor, Selma F. Witchel
    Image of study
    TLDR The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.
    The 2009 report by the Androgen Excess and PCOS Society Task Force established criteria for diagnosing polycystic ovary syndrome (PCOS), defining it by the presence of hyperandrogenism (clinical and/or biochemical), ovarian dysfunction (oligo-anovulation and/or polycystic ovaries), and the exclusion of related disorders. The Task Force reviewed literature from 1980 to 2005, focusing on studies with over 100 subjects, and found strong evidence of PCOS's familial pattern and its multifactorial polygenic nature. They reported that 67% of women with alopecia had polycystic ovaries, 36.5% of 109 premenopausal women with alopecia had PCOS, and 27.1% of women with menstrual dysfunction had PCOS. The prevalence of PCOS was higher in women with hirsutism compared to those with alopecia only. The report also discussed the prevalence of metabolic and reproductive abnormalities in PCOS, noting that 50% to 70% of women with PCOS have insulin resistance, and 33% to over 50% have metabolic syndrome in the US. Thyroid dysfunction and hyperprolactinemia were found to be relatively rare in PCOS patients. The Task Force recommended routine screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia (NC-CAH) in hyperandrogenic women, especially in high-risk populations, but not for Cushing's syndrome or androgen-secreting neoplasms unless symptoms are present. The report concluded that PCOS is primarily a hyperandrogenic disorder and that the definition of PCOS would likely evolve with new research findings.
    Discuss this study in the Community →

    Research cited in this study

    14 / 14 results

    Related Community Posts Join

    6 / 12 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 3 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  450 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 5 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Related Research

    2 / 2 results